Young Age and Male Sex Are Predictors of Large-Volume Central Neck Lymph Node Metastasis in Clinical N0 Papillary Thyroid Microcarcinomas
- PMID: 28741452
- DOI: 10.1089/thy.2017.0250
Young Age and Male Sex Are Predictors of Large-Volume Central Neck Lymph Node Metastasis in Clinical N0 Papillary Thyroid Microcarcinomas
Abstract
Background: Large-volume lymph node metastasis (LNM) is associated with poor clinical outcomes in papillary thyroid microcarcinoma (PTMC) patients. However, sensitivity in the detection of central neck LNM on preoperative neck ultrasonography (US) is believed to be low. The aim of this study is to investigate the preoperative clinical factors associated with large-volume LNM in clinical N0 PTMC patients.
Methods: In all, 2329 clinical N0 PTMC patients who underwent total thyroidectomy with prophylactic central lymph node (LN) dissection were evaluated. The LNM status of these patients was divided into three groups by the number of metastatic nodes: no LNM, small-volume LNM (≤5 metastatic LNs), and large-volume LNM (>5 metastatic LNs). The correlations between age, sex, and other clinical factors and large-volume LNM were evaluated.
Results: Large-volume LNM was found in 94 (4.0%) patients. Young (<40 years old) and male patients tended to have large-volume LNM (p for trend <0.001). Young age (odds ratio [OR] = 2.69 [confidence interval (CI) 1.64-4.32], p < 0.001) and male sex (OR = 5.79 [CI 3.67-9.10], p < 0.001) were independent risk factors for large-volume LNM in multivariate analyses. The prevalence of large-volume LNM ranged from 24% in male patients <40 years of age to only 2% in female patients aged ≥40 years. Multifocal tumors and presence of extrathyroidal extension were also considered risk factors for large-volume LNM.
Conclusions: Large-volume LNM was more frequently found in young (<40 years) and male patients. These findings support the notion that surgery rather than observation may be favored in young and male clinically LN negative PTMC patients as a primary therapeutic option.
Keywords: lymph node metastasis; male; papillary thyroid microcarcinoma; young age.
Similar articles
-
Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.J Int Med Res. 2017 Jun;45(3):1221-1230. doi: 10.1177/0300060517708943. Epub 2017 May 23. J Int Med Res. 2017. PMID: 28534700 Free PMC article.
-
Predicting large-volume lymph node metastasis in the clinically node-negative papillary thyroid microcarcinoma: a retrospective study.Nucl Med Commun. 2020 Jan;41(1):5-10. doi: 10.1097/MNM.0000000000001119. Nucl Med Commun. 2020. PMID: 31764592
-
Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.Ann Diagn Pathol. 2020 Dec;49:151647. doi: 10.1016/j.anndiagpath.2020.151647. Epub 2020 Oct 22. Ann Diagn Pathol. 2020. PMID: 33126150
-
The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1327-1338. doi: 10.1007/s00405-016-4302-0. Epub 2016 Sep 19. Eur Arch Otorhinolaryngol. 2017. PMID: 27645473 Review.
-
The Prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis.J Clin Endocrinol Metab. 2022 May 17;107(6):1589-1598. doi: 10.1210/clinem/dgac107. J Clin Endocrinol Metab. 2022. PMID: 35213704 Review.
Cited by
-
Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines.Endocrinol Metab (Seoul). 2024 Feb;39(1):47-60. doi: 10.3803/EnM.2024.1937. Epub 2024 Feb 15. Endocrinol Metab (Seoul). 2024. PMID: 38356210 Free PMC article. Review.
-
Prediction of central lymph node metastasis in patients with papillary thyroid microcarcinoma by gradient-boosting decision tree model based on ultrasound radiomics and clinical features.Gland Surg. 2023 Dec 26;12(12):1722-1734. doi: 10.21037/gs-23-456. Epub 2023 Dec 22. Gland Surg. 2023. PMID: 38229842 Free PMC article.
-
Occult Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma Patients Undergoing TOETVA Procedure.J Thyroid Res. 2023 Nov 30;2023:4779409. doi: 10.1155/2023/4779409. eCollection 2023. J Thyroid Res. 2023. PMID: 38074895 Free PMC article.
-
A prediction model for identifying high-risk lymph node metastasis in clinical low-risk papillary thyroid microcarcinoma.BMC Endocr Disord. 2023 Nov 27;23(1):260. doi: 10.1186/s12902-023-01521-0. BMC Endocr Disord. 2023. PMID: 38012653 Free PMC article.
-
Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance.Front Endocrinol (Lausanne). 2023 Sep 7;14:1235006. doi: 10.3389/fendo.2023.1235006. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37745712 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
